Medical Device R&D Summit
Organization: marcus evans
|Event Date/Time: Nov 18, 2013||End Date/Time: Nov 19, 2013|
The Medical Device R&D Summit will highlight the current challenges and opportunities for medical device R&D executives across North America through visionary keynote presentations and case studies delivered by your most esteemed peers and thought leaders. The one-on-one meetings with leading solution providers will offer a wealth of expertise in cutting-edge technology, strategy and implementation.
The primary objective of the Medical Device R&D Summit is to explore the key aspects and issues related to R&D best practices and their application as business drivers for innovation and growth. The Summit's program topics have been pinpointed and validated by senior executives from the medical device R&D community as the top critical issues they face.
Key issues for 2013 include:
-Changing Regulatory Environment – Interpreting FDA regulations and budgetary implications of the Medical Device Tax -Outsourcing R&D Activities – Staying abreast of the markets and increasing global competitiveness -Improving Time to Market in NPD – Applying Six Sigma to R&D processes -Effective R&D Spending – Selling the value of R&D to C-Suite and measuring the effectiveness of dollars spent -America Invents Act – Analyzing the newly implemented patent act from a Freedom to Operate perspective -Total Solution Approach to Innovation – Assuring continued growth through the development of innovative and competitive products -Promoting Innovation Through Difficult Times – Motivating R&D teams and retaining top talent -Inter-Departmental Cohesion – Maximizing the flow of information, materials and knowledge -Early Stage Supplier Selection – The role of R&D in supply chain management and securing the right partner
Key speakers include:
John Mazzola, Staff VP of Manufacturing Operations, CR Bard Inc. Philip Miller, VP NA R&D, Essilor International SA Dana J. Landry, PhD, NPDP, Senior Director R&D and Innovation Council Manager, Covidien Jennifer Ikeda, VP, R&D Innovation Strategy, Baxter International Ismael Villarreal, Director of Operations, Cardinal Health Inc.